- 
                            
                            Information-Publications- 
                                    
                                         Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A …Details Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A …Details
- 
                                    
                                         The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progressionDetails The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progressionDetails
- 
                                    
                                         A network pharmacology-based study on vital pharmacological pathways and targets of eucommiae cortex acting on osteoporosisDetails A network pharmacology-based study on vital pharmacological pathways and targets of eucommiae cortex acting on osteoporosisDetails
- 
                                    
                                         Lignin-Assisted local release of triiodothyronine in adipose tissue protects mice against obesity and related metabolic disordersDetails Lignin-Assisted local release of triiodothyronine in adipose tissue protects mice against obesity and related metabolic disordersDetails
- 
                                    
                                         GL-V9 induce apoptosis of CML cells via MAPK signaling pathway.Details GL-V9 induce apoptosis of CML cells via MAPK signaling pathway.Details
- 
                                    
                                         OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIsDetails OTUD1 stabilizes PTEN to inhibit the PI3K/AKT and TNF-alpha/NF-kappaB signaling pathways and sensitize ccRCC to TKIsDetails
 
- 
                                    
                                        
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
 
                         
                     
     
     
           
               Back
Back 
         
         
                         
                         
                             
                             
                             
                             
                             
                             
                            
 
             
             
                         
             
             
                         
         
                
         
                          
                         
                    